Macrogen, a global genome analysis company, has officially started building the largest Global Genome Center in Asia.The Incheon Free Economic Zone Authority announced that Macrogen held a groundbreaking ceremony on April 24 at the Advanced Industry Cluster in Songdo International City, Zone 5, for
Samsung Bioepis announced on April 23 that it has received final marketing authorization from the European Commission (EC) for Pyzchiva (project name SB17, ustekinumab), a biosimilar to Stelara. Pyzchiva’s active substance name is ustekinumab.Pyzchiva is the fourth autoimmune disease treatment devel
Coway, the “Best Life Solution Company," has received the 2024 Red Dot Award, marking its 18th consecutive win. The ongoing success is a testament to the company’s unwavering commitment to innovative design.The Red Dot Design Award is a prestigious international competition that celebrates design ex
HLB has opened an office in the Cambridge Innovation Center (CIC) in Boston, Massachusetts, in the United States, to strengthen its collaboration with global pharmaceutical giants and to support its subsidiaries’ expansion into overseas markets.Through the Boston office, HLB plans to strengthen comm
Osstem Implant, the world’s leading dental implant company in sales, faced measures including the recommendation for dismissal of its CEO following embezzlement amounting to around 220 billion won. The Securities and Futures Commission (SFC) under the Financial Services Commission resolved on such m
In the wake of overcoming a slump in the Chinese market, South Korea’s cosmetics exports have successfully diversified into markets such as the U.S., Japan, and Vietnam, showcasing a positive growth trend. According to a report released on April 18 by the Korea International Trade Association’s Inte
Kolmar Korea has discovered the hair loss mitigation effects of Sophora flavescens extract and has presented their findings at an international academic conference, marking the industry’s first such patent application. The discovery and subsequent presentation have garnered global attention.On April
bereum co.,ltd, a specialist in postbiotic, led by CEO Hwan Kwon Il, has signed an export and supply contract worth $980,000 for postbiotic pet food with Tecnocalidad of Colombia, under the leadership of CEO Harvey Ibanez Ortiz.Tecnocalidad is a subsidiary responsible for product imports of Agrocamp
Celltrion announced on April 11 that “Zymfentra” (the U.S. brand name for Remsima), the world’s first subcutaneous formulation of infliximab for the treatment of autoimmune diseases developed in-house, has completed its formulation patent registration with the United States Patent and Trademark Offi
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today that Prof. Dame Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), visited its headquarters located in Seoul Korea, on March 27.According to the company, Prof.
It is forecast that private investment in the field of biopharmaceuticals will reach 17.7 trillion won by 2030. To facilitate this, the government plans to allocate a budget of 2.1 trillion won for research and development (R&D), workforce training, and other initiatives to act as a facilitator.On A
Kolmar Group’s holding company, Kolmar Korea Holdings, is changing its name to Kolmar Holdings. This change reflects its aim to expand into the global market and establish its identity as an integrated brand.Kolmar Korea Holdings held a shareholders’ meeting on March 29 and decided to change its nam
Following the victory of the anti-merger faction led by brothers Lim Jong-yoon and Lim Jong-hoon, former presidents of Hanmi Pharmaceutical, in the proxy fight at the Hanmi Science shareholders’ meeting, the OCI Group declared the suspension of the merger process.OCI Holdings, the holding company of
Chey Min-jung, the younger daughter of Chey Tae-won, the chairman of SK Group, has recently founded a healthcare startup in the United States.According to industry sources on March 28, Min-jung has been listed as a co-founder of Integral Health, an AI-based healthcare startup established recently. T
Celltrion announced on March 25 that it has received a recommendation for marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) for the full label of its Xolair (active ingredient: omalizumab) biosimilar “CT-P39.”The original
Hanmi Group announced on March 25 that it has dismissed Lim Jong-yoon, president of Hanmi Science, and Lim Jong-hoon, president of Hanmi Pharmaceutical, effective March 25.The group stated that the two presidents caused disputes over important resolutions of the Hanmi Science board of directors, inf
The CEO of Osstem Implant allegedly made approximately 150 million won (US$111,431) in short-term trading profits by utilizing important undisclosed information before the company’s delisting.According to Osstem Implant’s business report for last year released on March 22, the company was informed o
SK bioscience announced on March 21 that it has shipped about 440,000 doses of cell-cultured influenza vaccine SKY Cellflu from Andong L-House to its Thai partner Biogenetech. SKY Cellflu is a vaccine of SK bioscience’s own development. The vaccine supplied this time is a strain for flu predicted fo
On March 15, Chong Kun Dang announced that as part of the Harvard Business School's 'Korea Trek 2024' program, 55 students visited its headquarters on March 13th.The Harvard Business School Korea Trek is a training program that introduces students to Korean culture, society, industry, and history. I
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced today that the company has shipped approximately 440,000 doses of SKYCellflu to Biogenetech in Thailand from its vaccine manufacturing facility ‘L HOUSE’ in Andong, S
